Dou Ke-feng

2.5k total citations
69 papers, 1.9k citations indexed

About

Dou Ke-feng is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Dou Ke-feng has authored 69 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Cancer Research and 18 papers in Hepatology. Recurrent topics in Dou Ke-feng's work include MicroRNA in disease regulation (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Cancer Cells and Metastasis (8 papers). Dou Ke-feng is often cited by papers focused on MicroRNA in disease regulation (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Cancer Cells and Metastasis (8 papers). Dou Ke-feng collaborates with scholars based in China, United States and Russia. Dou Ke-feng's co-authors include Kaishan Tao, Desheng Wang, Wenjie Song, Qingchuan Zhao, Zhi Song, Rui Li, Haimin Li, Zhenshun Song, Jianlin Wang and Bai Ruan and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Dou Ke-feng

67 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dou Ke-feng China 26 1.1k 632 502 280 245 69 1.9k
Wenxiu Zhao China 28 1.4k 1.3× 596 0.9× 577 1.1× 239 0.9× 242 1.0× 67 2.4k
Christèle Desbois‐Mouthon France 27 1.6k 1.5× 538 0.9× 689 1.4× 507 1.8× 371 1.5× 64 2.8k
Jiří Ehrmann Czechia 24 1.3k 1.2× 655 1.0× 777 1.5× 94 0.3× 200 0.8× 113 2.6k
Xiaoli Wu China 30 1.8k 1.6× 741 1.2× 438 0.9× 85 0.3× 272 1.1× 82 2.8k
Houjie Liang China 29 1.2k 1.1× 881 1.4× 711 1.4× 86 0.3× 157 0.6× 73 2.4k
Hisakazu Iwama Japan 26 1.1k 1.0× 547 0.9× 421 0.8× 103 0.4× 233 1.0× 101 1.9k
Zhihai Peng China 23 1.2k 1.0× 614 1.0× 325 0.6× 70 0.3× 144 0.6× 76 1.8k
Yuh-Lih Chang Taiwan 29 1.4k 1.3× 462 0.7× 568 1.1× 72 0.3× 141 0.6× 56 2.5k
Yuyan Han United States 25 638 0.6× 502 0.8× 259 0.5× 396 1.4× 423 1.7× 52 1.8k
Hongwei Lü China 23 814 0.7× 311 0.5× 191 0.4× 110 0.4× 244 1.0× 106 1.7k

Countries citing papers authored by Dou Ke-feng

Since Specialization
Citations

This map shows the geographic impact of Dou Ke-feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dou Ke-feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dou Ke-feng more than expected).

Fields of papers citing papers by Dou Ke-feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dou Ke-feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dou Ke-feng. The network helps show where Dou Ke-feng may publish in the future.

Co-authorship network of co-authors of Dou Ke-feng

This figure shows the co-authorship network connecting the top 25 collaborators of Dou Ke-feng. A scholar is included among the top collaborators of Dou Ke-feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dou Ke-feng. Dou Ke-feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Juanli, Jingjing Liu, Ping Song, et al.. (2025). Diabetes reshapes pancreatic cancer-associated endothelial niche by accelerating senescence. Nature Communications. 16(1). 8654–8654.
2.
Tian, Zelin, Zhibin Lin, Wenlong Wu, et al.. (2022). Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Frontiers in Immunology. 13. 984728–984728. 18 indexed citations
3.
Wu, Wenlong, Quancheng Wang, Dandan Han, et al.. (2021). Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection. Cancer Cell International. 21(1). 500–500. 22 indexed citations
4.
Feng, Xiaobin, Ruocai Xu, Xilin Du, et al.. (2014). Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study. The American Journal of Gastroenterology. 109(12). 1891–1899. 59 indexed citations
5.
Zhou, Liang, Weiguo Zhang, Desheng Wang, et al.. (2014). MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1. Oncology Reports. 32(4). 1734–1740. 26 indexed citations
6.
Zhang, Guangya, et al.. (2013). Application of pancreaticojejunostomy procedures selection strategy in pancreaticoduodenectomy. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 12(2). 124–127. 1 indexed citations
7.
Li, Qingjun, Su Wang, Liang Zhou, et al.. (2013). Expression and significance of miR-10b in hepatocellular carcinoma tissue samples. Zhonghua gan-dan waike zazhi. 19(2). 120–123. 1 indexed citations
8.
Yang, Yanling, Junjie Li, Ru Ji, et al.. (2013). Abnormal Chloride Homeostasis in the Substancia Nigra Pars Reticulata Contributes to Locomotor Deficiency in a Model of Acute Liver Injury. PLoS ONE. 8(5). e65194–e65194. 5 indexed citations
9.
10.
Liu, Weihui, Xing Wang, Nan You, et al.. (2012). Efficient Enrichment of Hepatic Cancer Stem-Like Cells from a Primary Rat HCC Model via a Density Gradient Centrifugation-Centered Method. PLoS ONE. 7(4). e35720–e35720. 19 indexed citations
11.
Zhang, Yi, Yonghui Liao, Desheng Wang, et al.. (2011). Altered expression levels of miRNAs in serum as sensitive biomarkers for early diagnosis of traumatic injury. Journal of Cellular Biochemistry. 112(9). 2435–2442. 23 indexed citations
12.
Liu, Jie, et al.. (2010). Study on Preparation of Adriamycin-loaded PLGA Nanoparticles in Vitro. Xiandai shengwu yixue jinzhan. 10(24). 4661–4663. 1 indexed citations
13.
Yi, Wei, Yang Sun, Xufeng Wei, et al.. (2010). Proteomic profiling of human bone marrow mesenchymal stem cells under shear stress. Molecular and Cellular Biochemistry. 341(1-2). 9–16. 26 indexed citations
14.
Ding, Rui, Shuang Han, Yuanyuan Lu, et al.. (2010). Overexpressed Id-1 is associated with patient prognosis and HBx expression in hepatitis B virus-related hepatocellular carcinoma. Cancer Biology & Therapy. 10(3). 299–307. 27 indexed citations
15.
Wang, Lin, Yaochun Wang, Xingbin Hu, et al.. (2009). Notch-RBP-J Signaling Regulates the Mobilization and Function of Endothelial Progenitor Cells by Dynamic Modulation of CXCR4 Expression in Mice. PLoS ONE. 4(10). e7572–e7572. 32 indexed citations
16.
Wang, Ting, Kan Wang, Qing Yao, et al.. (2009). Prospective Study on Combination of Electrical Impedance Scanning and Ultrasound in Estimating Risk of Development of Breast Cancer in Young Women. Cancer Investigation. 28(3). 295–303. 7 indexed citations
17.
Liu, Weihui, et al.. (2009). Replacing Hoechst33342 with Rhodamine123 in isolation of cancer stem-like cells from the MHCC97 cell line. Toxicology in Vitro. 24(2). 538–545. 23 indexed citations
18.
Song, Wenjie, Kaishan Tao, Rui Li, et al.. (2008). Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. International Journal of Clinical Practice. 62(8). 1212–1218. 193 indexed citations
19.
Wang, Yutong, Qihua Tan, Lili Sun, et al.. (2008). Possible therapeutic effect of a Traditional Chinese Medicine, Sinisan, on chronic restraint stress related disorders. Neuroscience Letters. 449(3). 215–219. 33 indexed citations
20.
Ke-feng, Dou. (2002). Treatment of acute pancreatitis with Ulinastatin: a report of 72 cases. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenxiu Zhao Breakdown of academic impact, for papers by Christèle Desbois‐Mouthon Breakdown of academic impact, for papers by Jiří Ehrmann Breakdown of academic impact, for papers by Xiaoli Wu Breakdown of academic impact, for papers by Houjie Liang Breakdown of academic impact, for papers by Hisakazu Iwama Breakdown of academic impact, for papers by Zhihai Peng Breakdown of academic impact, for papers by Yuh-Lih Chang Breakdown of academic impact, for papers by Yuyan Han Breakdown of academic impact, for papers by Hongwei Lü
Rankless by CCL
2026